| Development and validation of a next-generation sequencing panel for clinical pharmacogenetics L Ramudo-Cela, JM López-Martí, D Colmeiro-Echeberría, ... Farmacia Hospitalaria 44 (6), 243-253, 2020 | 9 | 2020 |
| Study of cases of abiraterone discontinuation due to toxicity in pre-chemotherapy after 1 year’s experience L Ramudo-Cela, J Balea-Filgueiras, JR Vizoso-Hermida, I Martín-Herranz Journal of Oncology Pharmacy Practice 23 (8), 615-619, 2017 | 8 | 2017 |
| Genetic analysis of clozapine metabolism in a patient with subtherapeutic clozapine plasma concentrations—the importance of CYP3A5: a case report E Okon-Rocha, L Ramudo-Cela, D Taylor Journal of Clinical Psychopharmacology 42 (6), 604-606, 2022 | 3 | 2022 |
| Desarrollo y validación de un panel de secuenciación masiva en paralelo para farmacogenética clínica L Ramudo-Cela, JM López-Martí, D Colmeiro-Echeberría, ... Farmacia Hospitalaria 44 (6), 243-253, 2020 | 3 | 2020 |
| Coronary vascular disease event risk and metabolic syndrome prevalence in patients enrolled in an assertive treatment community program. L Ramudo Cela, MJ Avila Gonzalez, JC Yanez Rubal, LM Diaz Platas, ... | 2 | 2018 |
| Combining familial hypercholesterolemia and statin genetic studies as a strategy for the implementation of pharmacogenomics. A multidisciplinary approach L Ramudo-Cela, S Santana-Martínez, M García-Ramos, M Bergamino, ... The Pharmacogenomics Journal 22 (3), 180-187, 2022 | 1 | 2022 |
| Results of the implementation of a pharmacogenomics platform based on NGS technologies. Combining clinical and research approaches L Ramudo-Cela, F Busto-Fernández, M Outeda-Macíasz, S Antolín, ... Farmacia Hospitalaria 45, 11-37, 2021 | 1 | 2021 |
| Relación entre la pureza radioquímica del 123i-ioflupano y la captación extracraneal (tiroidea y parotídea) L Díaz Platas, S Prado Wohlwend, M Romero Otero, A Iniesta Medel, ... Ars Pharmaceutica (Internet) 56 (4), 225-230, 2015 | 1 | 2015 |
| Desarrollo de un servicio avanzado de la farmacogenética clínica: integración de abordajes genómicos y de tecnologías de la información L Ramudo Cela | | 2022 |
| Resultados de implementación de una plataforma farmacogenómica basada en tecnologías NGS. Combinación de abordajes asistencial y de investigación L Ramudo-Cela, F Busto-Fernández, M Outeda-Macías, S Antolín, ... Farmacia Hospitalaria 45 (07), 11-37, 2021 | | 2021 |
| Coronary vascular disease event risk and metabolic syndrome prevalence in patients enrolled in an assertive treatment community program LR Cela, MJÁ González, JCY Rubal, LMD Platas, MIM Herranz, ... Comprehensive Psychiatry 81, 28-32, 2018 | | 2018 |
| Acute-phase reactants in daptomycin induced pneumonia LR Cela, EL Álvarez, JCY Rubal, IM Herranz Revista espanola de geriatria y gerontologia 51 (5), 305-306, 2016 | | 2016 |
| Los reactantes de fase aguda en la neumonía inducida por daptomicina LR Cela, EL Alvarez, JCY Rubal, IM Herranz Revista española de geriatría y gerontología: Órgano oficial de la Sociedad …, 2016 | | 2016 |
| PS-090 Protocol for the safe use of intravenous potassium chloride: preparation of solutions in the pharmacy department P Salvador-Garrido, IP Vazquez, BF Cortizas, LR Cela, IM Herranz European Journal of Hospital Pharmacy: Science and Practice 21 (Suppl 1 …, 2014 | | 2014 |
| A study of the efficiency and output of the intravenous mixtures preparation unit L Elberdin Pazos, B Feal Cortizas, M Garcia Queiruga, L Ramudo Cela, ... INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 35 (6), 1339-1339, 2013 | | 2013 |
